Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Ardea Biosciences, Inc.-Detailed Product Pipeline

136 views

Published on

Ardea Biosciences, Inc.-Detailed Product Pipeline contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones. Scope of the reportsEach Life Science Analytics' Pipeline Report provides the user with real detail on a company's pipeline. In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive information in tabular and graphical formats on a company's product pipeline and disease hub classification.Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information. Every report also includes detail on a company's deals and alliances and recent corporate news including key milestones.Key benefitsUnderstand a company's strategic position by accessing detailed independent intelligence on its product pipeline.Keep track of your competitors and partners by better understanding their product pipeline.Monitor a company's research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.

Published in: Business, News & Politics
  • Be the first to comment

  • Be the first to like this

Ardea Biosciences, Inc.-Detailed Product Pipeline

  1. 1. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Ardea Biosciences, Inc.-Detailed Product PipelinePublished on September 2010 Report SummaryArdea Biosciences, Inc.-Detailed Product Pipeline contains detailed information on pipelines by phase and therapeutic indication aswell as management information,deals and alliances and recent news on the company including key milestones.Scope of the reportsEach Life Science Analytics Pipeline Report provides the user with real detail on a companys pipeline.In addition to business summaries, contact information, company details and selected financial data, each report also containsextensive information in tabular and graphical formats on a companys product pipeline and disease hub classification.Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information.Every report also includes detail on a companys deals and alliances and recent corporate news including key milestones.Key benefitsUnderstand a companys strategic position by accessing detailed independent intelligence on its product pipeline.Keep track of your competitors and partners by better understanding their product pipeline.Monitor a companys research effectiveness by determining pipeline depth and numbers of products in development by clinical phase. Table of ContentBusiness SummaryHeadquartersFinancialsProduct Glance--Products by Phase of Development--Products by Disease Hub Classification--Products by IndicationUpcoming MilestonesProduct PipelineProduct DetailsRecent Updates--Product UpdatesArdea Biosciences, Inc.-Detailed Product Pipeline Page 1/4
  2. 2. Find Industry reports, Company profilesReportLinker and Market StatisticsArdea Biosciences, Inc.-Detailed Product Pipeline Page 2/4
  3. 3. Find Industry reports, Company profilesReportLinker and Market Statistics Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. Ardea Biosciences, Inc.-Detailed Product Pipeline Product Formats Please select the product formats and the quantity you require. 1 User License--USD 750.00 Quantity: _____ Corporate License--USD 1 875.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________Ardea Biosciences, Inc.-Detailed Product Pipeline Page 3/4
  4. 4. Find Industry reports, Company profilesReportLinker and Market Statistics Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93Ardea Biosciences, Inc.-Detailed Product Pipeline Page 4/4

×